The Else Kröner Fresenius Foundation (EKFS) will continue to fund the research school “Therapy Resistance of Solid Tumors” until the end of 2024. The research school supports physicians from the fields of neurology, neurosurgery, radiation oncology and internal medicine as “clinician scientists” on their way to becoming specialists and obtaining a habilitation.
The research college "Therapy Resistance of Solid Tumors" will continue to be funded by the Else Kröner-Fresenius Foundation (EKFS) until the end of 2024. The college supports physicians from the fields of neurology, neurosurgery, radiation oncology and internal medicine on their way as "clinician scientists" to becoming specialists and to postdoctoral lecturing qualification.
The research school addresses a relevant challenge in the treatment of tumor patients: acquired therapy resistance. Most patients initially respond well to therapeutic strategies. At a later stage, their tumor often “learns” to escape drug treatment and use alternative routes. This is particularly the case with therapeutic strategies that specifically block molecular signaling pathways.
The fellows will work in designated research teams on projects that will contribute to knowledge in this field. They will learn innovative methods in basic science as well as important approaches for clinical translation and trial design. The curriculum further comprises lab rotations, mentoring, and an interdisciplinary seminar program. The goal of the research school is to dovetail research activities and residency training and to bridge critical career phases, for example, directly after the start of postgraduate training or after a return from abroad.
The spokesperson of the research school is Professor Dr. Dr. Ghazaleh Tabatabai, Director of the Department of Neurology and Interdisciplinary Neuro-Oncology. New fellows are Dr. Elgin Hoffmann (since 01.01.22), Hannes Becker (since 01.02.22) and Dr. Sylvia Kurz (since 01.03.22). Further candidates will follow in the next years.
Copyright: Fabian Zapatka / HIH
